TickerFacts.

Orthofix Medical Inc. (OFIX): Shareholders' Equity

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2011-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

$450.04M
As of 2025-12-31
$429.18M
As of 2026-06-30
+10.1%
3-year compound annual growth
+4.7%
5-year compound annual growth
+4.5%
10-year compound annual growth
$598.73M2009-12-31: $240.27M2010-12-31: $300.89M2011-03-31: $263.99M2011-06-30: $279.98M2011-09-30: $292.09M2011-12-31: $280.30M2012-03-31: $298.55M2012-06-30: $312.92M2012-09-30: $332.42M2012-12-31: $356.44M2013-03-31: $360.98M2013-06-30: $332.15M2013-09-30: $306.99M2013-12-31: $295.86M2014-03-31: $300.56M2014-06-30: $305.21M2014-09-30: $305.02M2014-12-31: $299.63M2015-12-31: $290.31M2016-12-31: $263.48M2017-12-31: $296.61M2018-12-31: $335.40M2019-12-31: $327.63M2020-12-31: $356.86M2021-12-31: $336.93M2022-12-31: $336.86M2023-12-31: $598.73M2024-12-31: $503.12M2025-12-31: $450.04M$450.04M
2009-12-31 Shareholders' Equity (USD) 2025-12-31
Period endedShareholders' EquityChange YoYSource filing
2025-12-31$450.04M-10.6%2026-02-24, Balance as of period end
2024-12-31$503.12M-16.0%2026-02-24, Balance as of period end
2023-12-31$598.73M+77.7%2026-02-24, Balance as of period end
2022-12-31$336.86M0.0%2025-02-25, Balance as of period end
2021-12-31$336.93M-5.6%2024-03-05, Balance as of period end
2020-12-31$356.86M+8.9%2023-03-06, Balance as of period end
2019-12-31$327.63M-2.3%2022-02-25, Balance as of period end
2018-12-31$335.40M+13.1%2021-02-26, Balance as of period end
2017-12-31$296.61M+12.6%2020-02-24, Balance as of period end
2016-12-31$263.48M-9.2%2019-02-25, Balance as of period end
2015-12-31$290.31M-3.1%2018-02-26, Balance as of period end
2014-12-31$299.63Mn/a2017-02-27, Balance as of period end
2014-09-30$305.02Mn/a2015-04-29, Balance as of period end
2014-06-30$305.21Mn/a2015-04-29, Balance as of period end
2014-03-31$300.56Mn/a2015-04-29, Balance as of period end
2013-12-31$295.86Mn/a2016-02-29, Balance as of period end
2013-09-30$306.99Mn/a2015-04-29, Balance as of period end
2013-06-30$332.15Mn/a2015-04-29, Balance as of period end
2013-03-31$360.98Mn/a2015-04-29, Balance as of period end
2012-12-31$356.44Mn/a2015-04-29, Balance as of period end
2012-09-30$332.42Mn/a2015-03-31, Balance as of period end
2012-06-30$312.92Mn/a2015-03-31, Balance as of period end
2012-03-31$298.55Mn/a2015-03-31, Balance as of period end
2011-12-31$280.30Mn/c2015-03-31, Balance as of period end
2011-09-30$292.09Mn/a2014-03-24, Balance as of period end
2011-06-30$279.98Mn/a2014-03-24, Balance as of period end
2011-03-31$263.99Mn/a2014-03-24, Balance as of period end
2010-12-31$300.89M+25.2%2012-02-29, Balance as of period end
2009-12-31$240.27Mn/a2012-02-29, Balance as of period end

Shareholders' Equity at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedShareholders' EquityChange YoY
Orthofix Medical Inc. (OFIX)2025-12-31$450.04M-10.6%
Alphatec Holdings, Inc. (ATEC)2025-12-31$12.43Mn/m
iRhythm Holdings, Inc. (IRTC)2025-12-31$152.75M+68.0%
Inspire Medical Systems, Inc. (INSP)2025-12-31$781.16M+13.3%
Tandem Diabetes Care Inc (TNDM)2025-12-31$155.17M-41.0%
NovoCure Ltd (NVCR)2025-12-31$340.47M-5.5%
Embecta Corp. (EMBC)2025-09-30-$650.60Mn/m
UFP Technologies Inc (UFPT)2025-12-31$423.88M+23.7%
Bioventus Inc. (BVS)2025-12-31$184.10M+24.4%

Compare OFIX, ATEC, IRTC, INSP side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗